Jo Ann LeQuang
Overview
Explore the profile of Jo Ann LeQuang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
480
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pergolizzi Jr J, LeQuang J
Pain Manag
. 2025 Feb;
15(3):141-147.
PMID: 39987468
Health literacy has a broad range of impacts, including whether and where a person seeks treatment and how well that patient interprets and applies clinical recommendations. Patients with headache may...
2.
Pergolizzi Jr J, LeQuang J, Coluzzi F, El-Tallawy S, Magnusson P, Ahmed R, et al.
Expert Opin Pharmacother
. 2024 Nov;
25(17):2267-2282.
PMID: 39540855
Introduction: Endometriosis affects 5% to 10% of reproductive age women and may be associated with severely painful and debilitating symptoms as well as infertility. Endometriosis involves hormonal fluctuations, angiogenesis, neurogenesis,...
3.
Coluzzi F, Scerpa M, Loffredo C, Borro M, Pergolizzi J, LeQuang J, et al.
Int J Mol Sci
. 2024 Jul;
25(14).
PMID: 39063241
Opioids are commonly used for the management of severe chronic cancer pain. Their well-known pharmacological effects on the gastrointestinal system, particularly opioid-induced constipation (OIC), are the most common limiting factors...
4.
Pergolizzi Jr J, LeQuang J, El-Tallawy S, Wagner M, Ahmed R, Varrassi G
Expert Rev Neurother
. 2024 Jun;
24(8):773-786.
PMID: 38870050
Introduction: Trigeminal neuralgia is a rare condition that can be effectively treated by carbamazepine or oxcarbazepine but these older drugs are associated with dose-dependent and potentially treatment-limiting adverse effects. Third-generation...
5.
Pergolizzi Jr J, LeQuang J, Magnusson P, Varrassi G
Expert Rev Neurother
. 2023 Nov;
23(12):1297-1310.
PMID: 37999989
Introduction: Chronic postsurgical pain (CPSP) is a prevalent condition that can diminish health-related quality of life, cause functional deficits, and lead to patient distress. Rates of CPSP are higher for...
6.
Pergolizzi Jr J, LeQuang J, Varrassi M, Breve F, Magnusson P, Varrassi G
Adv Ther
. 2023 Jan;
40(4):1334-1346.
PMID: 36692679
The most common type of idiopathic interstitial pneumonia is idiopathic pulmonary fibrosis (IPF), an irreversible, progressive disorder that has lately come into question for possible associations with COVID-19. With few...
7.
LeQuang J
J Clin Aesthet Dermatol
. 2022 Nov;
15(11 Suppl 1):S3-S15.
PMID: 36405422
Risk-stratification of cancer, traditionally performed through staging, directs optimal disease management decisions with the result of improved patient outcomes. Many forms of cutaneous cancer have overall excellent survival rates, but...
8.
Pergolizzi Jr J, Gharibo C, Magnusson P, Breve F, LeQuang J, Varrassi G
Expert Opin Pharmacother
. 2022 Jun;
23(10):1155-1164.
PMID: 35695796
Introduction: Guidelines recommend a number of pharmacotherapeutic options used as monotherapy or in combination with others for treating the pain of trigeminal neuropathy. Areas Covered: The authors examine the pharmacotherapeutic...
9.
Pergolizzi Jr J, Magnusson P, Christo P, LeQuang J, Breve F, Mitchell K, et al.
Front Pain Res (Lausanne)
. 2022 Mar;
2:691720.
PMID: 35295520
A clinical conundrum can occur when a patient with active opioid use disorder (OUD) or at elevated risk for the condition presents with cancer and related painful symptoms. Despite earlier...
10.
Pergolizzi Jr J, Fort P, Miller T, LeQuang J, Raffa R
J Clin Pharm Ther
. 2022 Jan;
47(5):685-693.
PMID: 35018653
What Is Known And Objective: Many premature infants less than 37 weeks gestational age (GA), and almost all infants less than 28 weeks GA, will experience apnoea of prematurity (AOP)-a...